1. Home
  2. IPW vs BLRX Comparison

IPW vs BLRX Comparison

Compare IPW & BLRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo iPower Inc.

IPW

iPower Inc.

HOLD

Current Price

$1.39

Market Cap

4.1M

ML Signal

HOLD

Logo BioLineRx Ltd.

BLRX

BioLineRx Ltd.

HOLD

Current Price

$2.28

Market Cap

12.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IPW
BLRX
Founded
2018
2003
Country
United States
Israel
Employees
N/A
N/A
Industry
Catalog/Specialty Distribution
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.1M
12.6M
IPO Year
2021
2010

Fundamental Metrics

Financial Performance
Metric
IPW
BLRX
Price
$1.39
$2.28
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$19.00
AVG Volume (30 Days)
96.3K
13.0K
Earning Date
05-14-2026
03-23-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$66,142,779.00
N/A
Revenue This Year
$149.67
N/A
Revenue Next Year
$15.04
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.43
$2.28
52 Week High
$29.10
$7.77

Technical Indicators

Market Signals
Indicator
IPW
BLRX
Relative Strength Index (RSI) 28.17 32.44
Support Level $0.50 N/A
Resistance Level $2.79 $3.93
Average True Range (ATR) 0.21 0.18
MACD 0.06 -0.03
Stochastic Oscillator 0.34 0.00

Price Performance

Historical Comparison
IPW
BLRX

About IPW iPower Inc.

iPower Inc is a United States-based online retailer and supplier of consumer home, pet, garden, outdoor, and consumer electronics products. It also operates as a provider of value-added ecommerce services for third-party products and brands. The company's capabilities include a spectrum of online channels, fulfillment capacity, a network of warehouses serving the U.S., last-mile delivery partners, and a differentiated business intelligence platform. The company's sales channels currently include Amazon Vendor, Amazon 3P, Walmart.com, TikTok, Temu, and other marketplaces, as well as its own e-commerce websites, such as simpledeluxe.com and more. Additionally, it is developing in-house branded products and through supply chain partners, which include iPower, Simple Deluxe, and other brands.

About BLRX BioLineRx Ltd.

BioLine Rx Ltd is a commercial-stage biopharmaceutical company focused on oncology. The company's current development and commercialization pipeline consists of two clinical-stage therapeutic candidates motixafortide (BL-8040), a novel peptide for the treatment of stem-cell mobilization and solid tumors, and AGI-134, an immuno-oncology agent in development for solid tumors. In addition, the company has a legacy therapeutic product called BL-5010 for the treatment of skin lesions. The company has generated revenues from milestone payments under previously existing out-licensing agreements.

Share on Social Networks: